Clinical features | Values |
---|---|
No of patients | 21 |
Age (years) | 49.6 (24–76) |
FIGO stage: | Â |
 II | 11 (52.4 %) |
 III | 6 (28.6 %) |
 IV | 4 (19.0 %) |
Metastasis (n = 4) | |
 Bladder | 1 (4.8 %) |
 Rectum | 3 (14.3 %) |
Treatment outcome | Â |
Complete response | 18 (85.7Â %) |
Partial response | 3 (14.3Â %) |